Nutr Res Pract.  2023 Aug;17(4):682-697. 10.4162/nrp.2023.17.4.682.

In-silico annotation of the chemical composition of Tibetan tea and its mechanism on antioxidant and lipidlowering in mice

Affiliations
  • 1College of Bioengineering, Sichuan University of Science and Engineering, Zigong 643000, China
  • 2Luzhou LaoJiao Group Co. Ltd., Luzhou 646000, China
  • 3College of Horticulture, Hunan Agricultural University, Changsha 410128, China
  • 4Department of Bioinformatics and Biotechnology, Government College University Faisalabad, Faisalabad, 38000, Pakistan
  • 5Ya’an Youyi Tea Co., Ltd, Ya’an 625000, China
  • 6Comprehensive Agricultural Service Center of Dachuan, Lushan, Ya’an 625000, China
  • 7School of Food and Biological Engineering, Xihua University, Chengdu 610039, China

Abstract

BACKGROUND/OBJECTIVES
Tibetan tea is a kind of dark tea, due to the inherent complexity of natural products, the chemical composition and beneficial effects of Tibetan tea are not fully understood. The objective of this study was to unravel the composition of Tibetan tea using knowledge-guided multilayer network (KGMN) techniques and explore its potential antioxidant and hypolipidemic mechanisms in mice.
MATERIALS/METHODS
The C57BL/6J mice were continuously gavaged with Tibetan tea extract (T group), green tea extract (G group) and ddH 2 O (H group) for 15 days. The activity of total antioxidant capacity (T-AOC) and superoxide dismutase (SOD) in mice was detected. Transcriptome sequencing technology was used to investigate the molecular mechanisms underlying the antioxidant and lipid-lowering effects of Tibetan tea in mice. Furthermore, the expression levels of liver antioxidant and lipid metabolism related genes in various groups were detected by the real-time quantitative polymerase chain reaction (qPCR) method.
RESULTS
The results showed that a total of 42 flavonoids are provisionally annotated in Tibetan tea using KGMN strategies. Tibetan tea significantly reduced body weight gain and increased T-AOC and SOD activities in mice compared with the H group. Based on the results of transcriptome and qPCR, it was confirmed that Tibetan tea could play a key role in antioxidant and lipid lowering by regulating oxidative stress and lipid metabolism related pathways such as insulin resistance, P53 signaling pathway, insulin signaling pathway, fatty acid elongation and fatty acid metabolism.
CONCLUSIONS
This study was the first to use computational tools to deeply explore the composition of Tibetan tea and revealed its potential antioxidant and hypolipidemic mechanisms, and it provides new insights into the composition and bioactivity of Tibetan tea.

Keyword

Tea; lipid metabolism; antioxidant; transcriptome

Figure

  • Fig. 1 Annotation of unknown metabolites using recursive network algorithm. The compounds in Tibetan tea were identified by non-targeted UPLC-Q-TOF mass spectrometry combined with KGMN analysis, and a total of 17 recursive steps were performed.KGMN, knowledge-guided multilayer network.

  • Fig. 2 Effects of green tea and Tibetan tea on the body parameters of mice. Mice were randomly divided into 3 experimental groups: ddH2O group (control; H), Tibetan tea extract group (T), Green tea extract group (G). (A) Body weights. (B) The activity of T-AOC in serum and liver (serum: U/mL and liver: U/g). (C) SOD activity in serum and liver (serum: U/mL and liver: U/g). The data are expressed as the mean ± SD.T-AOC, total antioxidant capacity; SOD, superoxide dismutase.*P < 0.05, **P < 0.01, ***P < 0.005 vs. the H group.

  • Fig. 3 Transcriptome analysis of mice liver. Mice liver type were divided into 3 groups: ddH2O group mice liver (LH), Tibetan tea extract group mice liver (LT), and green tea extract mice liver (LG). (A) Principal component analysis results. The abscissa is the first principal component, and the ordinate is the second principal component. (B) Venn diagram of coexpression. (C) Statistical histogram of the number of differentially compared genes in combination. Grey and blue represent up-regulated and down-regulated differential genes, respectively, and the numbers on the bars represent the number of differential genes.

  • Fig. 4 GO enrichment analysis. The abscissa is the GO term, and the ordinate is the significance level of GO term enrichment. Mice liver type were divided into 3 groups: ddH2O group mice liver (LH), Tibetan tea extract group mice liver (LT), and green tea extract group mice liver (LG). (A) LG vs. LH. (B) LT vs. LH.GO, Gene Ontology; BP, biological process; CC, cellular component; MF, molecular function.

  • Fig. 5 KEGG pathway enrichment analysis. The abscissa is the ratio of the number of differential genes annotated in the KEGG pathway to the total number of differential genes, and the ordinate is the KEGG pathway. Mice liver type were divided into 3 groups: ddH2O group mice liver (LH), Tibetan tea extract group mice liver (LT), and green tea extract group mice liver (LG). (A) LT vs. LH. (B) LG vs. LH.KEGG, Kyoto Encyclopedia of Genes and Genomes.

  • Fig. 6 The relative mRNA expression levels of Cu/Zn-SOD (A), Mn-SOD (B), GSH-Px (C), PPAR-α (D), LDLR (E), CPT-1a (F), C/EBP-α (G), FAS (H), SREBP-1c (I) in liver tissues. Mice were randomly divided into 3 experimental groups: ddH2O group (H), Tibetan tea extract group (T), and green tea extract group (G). Bar graphs depicting the mean ± standard deviation mRNA expression levels of antioxidant genes and lipid metabolism related genes in liver tissue of male C57BL/6J mice. Antioxidant genes: Cu/Zn-SOD (A), Mn-SOD (B), GSH-Px (C); lipid metabolism related genes: PPAR-α (D), LDLR (E), CPT-1a (F), C/EBP-α (G), FAS (H), SREBP-1c (I). Cu/Zn-SOD, copper/zinc superoxide dismutase; Mn-SOD, manganese superoxide dismutase; GSH-Px, Plasma glutathione peroxidase; PPAR-α, peroxisome proliferator-activated receptor alpha; LDLR, low-density lipoprotein receptor; CPT-1a, carnitine palmitoyltransferase-1a; C/EBP-α, CCAAT/enhancer binding proteins alpha; FAS, fatty acid synthase; SREBP-1c, sterol regulatory element-binding protein-1c.*P < 0.05 vs. H group.


Reference

1. Xiao Y, He C, Chen Y, Ho CT, Wu X, Huang Y, Gao Y, Hou A, Li Z, Wang Y, et al. UPLC-QQQ-MS/MS-based widely targeted metabolomic analysis reveals the effect of solid-state fermentation with Eurotium cristatum on the dynamic changes in the metabolite profile of dark tea. Food Chem. 2022; 378:131999. PMID: 35081481.
2. Xie H, Li X, Ren Z, Qiu W, Chen J, Jiang Q, Chen B, Chen D. Antioxidant and cytoprotective effects of Tibetan tea and its phenolic components. Molecules. 2018; 23:179. PMID: 29364183.
Article
3. Liu Y, Huang W, Zhang C, Li C, Fang Z, Zeng Z, Hu B, Chen H, Wu W, Wang T, et al. Targeted and untargeted metabolomic analyses and biological activity of Tibetan tea. Food Chem. 2022; 384:132517. PMID: 35228002.
Article
4. Wang S, Qiu Y, Gan RY, Zhu F. Chemical constituents and biological properties of Pu-erh tea. Food Res Int. 2022; 154:110899. PMID: 35337597.
Article
5. Zhu J, Yu C, Zhou H, Wei X, Wang Y. Comparative evaluation for phytochemical composition and regulation of blood glucose, hepatic oxidative stress and insulin resistance in mice and HepG2 models of four typical Chinese dark teas. J Sci Food Agric. 2021; 101:6563–6577. PMID: 34018615.
Article
6. Long P, Wen M, Granato D, Zhou J, Wu Y, Hou Y, Zhang L. Untargeted and targeted metabolomics reveal the chemical characteristic of pu-erh tea (Camellia assamica) during pile-fermentation. Food Chem. 2020; 311:125895. PMID: 31780220.
7. DesRochers N, Walsh JP, Renaud JB, Seifert KA, Yeung KK, Sumarah MW. Metabolomic profiling of fungal pathogens responsible for root rot in American ginseng. Metabolites. 2020; 10:35. PMID: 31947697.
Article
8. Reveglia P, Raimondo ML, Masi M, Cimmino A, Nuzzo G, Corso G, Fontana A, Carlucci A, Evidente A. Untargeted and targeted LC-MS/MS based metabolomics study on in vitro culture of Phaeoacremonium species. J Fungi (Basel). 2022; 8:55. PMID: 35049995.
Article
9. Xu J, Liang X, Wang W, Chen S, Tang Q. Study on anti-radiation effect of Ya’an Tibetan tea. J Phys Conf Ser. 2020; 1549:032049.
Article
10. Blaženović I, Kind T, Ji J, Fiehn O. Software tools and approaches for compound identification of LC-MS/MS data in metabolomics. Metabolites. 2018; 8:31. PMID: 29748461.
Article
11. Zhou Z, Luo M, Zhang H, Yin Y, Cai Y, Zhu ZJ. Metabolite annotation from knowns to unknowns through knowledge-guided multi-layer metabolic network. bioRxiv. 2022; 6:494523.
Article
12. Zheng Q, Li W, Zhang H, Gao X, Tan S. Optimizing synchronous extraction and antioxidant activity evaluation of polyphenols and polysaccharides from Ya’an Tibetan tea (Camellia sinensis). Food Sci Nutr. 2019; 8:489–499. PMID: 31993173.
Article
13. Li L, Shi M, Salerno S, Tang M, Guo F, Liu J, Feng Y, Fu M, Huang Q, Ma L, et al. Microbial and metabolomic remodeling by a formula of Sichuan dark tea improves hyperlipidemia in apoE-deficient mice. PLoS One. 2019; 14:e0219010. PMID: 31269076.
Article
14. Xu J, Sun R, Wang J. Human trial of health effects of Tibetan tea. Food Res Dev. 2017; 38:168–171.
15. Tsugawa H, Ikeda K, Takahashi M, Satoh A, Mori Y, Uchino H, Okahashi N, Yamada Y, Tada I, Bonini P, et al. A lipidome atlas in MS-DIAL 4. Nat Biotechnol. 2020; 38:1159–1163. PMID: 32541957.
Article
16. Pandurangan AK, Ismail S, Saadatdoust Z, Esa NM. Allicin alleviates dextran sodium sulfate- (DSS-) induced ulcerative colitis in BALB/c mice. Oxid Med Cell Longev. 2015; 2015:605208. PMID: 26075036.
Article
17. Shi J, Ma W, Wang C, Wu W, Tian J, Zhang Y, Shi Y, Wang J, Peng Q, Lin Z, et al. Impact of various microbial-fermented methods on the chemical profile of dark tea using a single raw tea material. J Agric Food Chem. 2021; 69:4210–4222. PMID: 33792297.
Article
18. Zhu MZ, Li N, Zhou F, Ouyang J, Lu DM, Xu W, Li J, Lin HY, Zhang Z, Xiao JB, et al. Microbial bioconversion of the chemical components in dark tea. Food Chem. 2020; 312:126043. PMID: 31896450.
Article
19. Wang Y, Kan Z, Thompson HJ, Ling T, Ho CT, Li D, Wan X. Impact of six typical processing methods on the chemical composition of tea leaves using a single Camellia sinensis cultivar, Longjing 43. J Agric Food Chem. 2019; 67:5423–5436. PMID: 30403138.
Article
20. Al-Ishaq RK, Abotaleb M, Kubatka P, Kajo K, Büsselberg D. Flavonoids and their anti-diabetic effects: cellular mechanisms and effects to improve blood sugar levels. Biomolecules. 2019; 9:430. PMID: 31480505.
Article
21. Zuo L, Prather ER, Stetskiv M, Garrison DE, Meade JR, Peace TI, Zhou T. Inflammaging and oxidative stress in human diseases: from molecular mechanisms to novel treatments. Int J Mol Sci. 2019; 20:4472. PMID: 31510091.
Article
22. Phaniendra A, Jestadi DB, Periyasamy L. Free radicals: properties, sources, targets, and their implication in various diseases. Indian J Clin Biochem. 2015; 30:11–26. PMID: 25646037.
Article
23. Nobari H, Saedmocheshi S, Chung LH, Suzuki K, Maynar-Mariño M, Pérez-Gómez J. An overview on how exercise with green tea consumption can prevent the production of reactive oxygen species and improve sports performance. Int J Environ Res Public Health. 2021; 19:218. PMID: 35010479.
Article
24. Mu S, Yang W, Huang G. Antioxidant activities and mechanisms of polysaccharides. Chem Biol Drug Des. 2021; 97:628–632. PMID: 32946177.
Article
25. Song Y, Hui J, Kou W, Xin R, Jia F, Wang N, Hu F, Zhang H, Liu H. Identification of Inonotus obliquus and analysis of antioxidation and antitumor activities of polysaccharides. Curr Microbiol. 2008; 57:454–462. PMID: 18795365.
Article
26. Hernández Borrero LJ, El-Deiry WS. Tumor suppressor p53: biology, signaling pathways, and therapeutic targeting. Biochim Biophys Acta Rev Cancer. 2021; 1876:188556. PMID: 33932560.
Article
27. Tu Y, Chen D, Pan T, Chen Z, Xu J, Jin L, Sheng L, Jin X, Wang X, Lan X, et al. Inhibition of miR-431-5p attenuated liver apoptosis through KLF15/p53 signal pathway in S100 induced autoimmune hepatitis mice. Life Sci. 2021; 280:119698. PMID: 34111466.
Article
28. Jazvinšćak Jembrek M, Oršolić N, Mandić L, Sadžak A, Šegota S. Anti-oxidative, anti-inflammatory and anti-apoptotic effects of flavonols: targeting Nrf2, NF-κB and p53 pathways in neurodegeneration. Antioxidants. 2021; 10:1628. PMID: 34679762.
Article
29. Seo DB, Jeong HW, Cho D, Lee BJ, Lee JH, Choi JY, Bae IH, Lee SJ. Fermented green tea extract alleviates obesity and related complications and alters gut microbiota composition in diet-induced obese mice. J Med Food. 2015; 18:549–556. PMID: 25764354.
Article
30. Wang C, Liu J, Sang S, Ao X, Su M, Hu B, Li H. Effects of tea treatments against high-fat diet-induced disorder by regulating lipid metabolism and the gut microbiota. Comput Math Methods Med. 2022; 2022:9336080. PMID: 35677179.
Article
31. Liu C, Guo Y, Sun L, Lai X, Li Q, Zhang W, Xiang L, Sun S, Cao F. Six types of tea reduce high-fat-diet-induced fat accumulation in mice by increasing lipid metabolism and suppressing inflammation. Food Funct. 2019; 10:2061–2074. PMID: 30907897.
Article
32. Li N, Zhou X, Wang J, Chen J, Lu Y, Sun Y, Song Y, Tan X, Xie G, Chen Y, et al. White tea alleviates non-alcoholic fatty liver disease by regulating energy expenditure and lipid metabolism. Gene. 2022; 833:146553. PMID: 35569768.
Article
33. Hussain K, Yang Y, Wang J, Bian H, Lei X, Chen J, Li Q, Wang L, Zhong Q, Fang X, et al. Comparative study on the weight loss and lipid metabolism by tea polyphenols in diet induced obese C57BL/6J pseudo germ free and conventionalized mice. Food Sci Hum Well. 2022; 11:697–710.
Article
34. Cho D, Jeong HW, Kim JK, Kim AY, Hong YD, Lee JH, Choi JK, Seo DB. Gallocatechin gallate-containing fermented green tea extract ameliorates obesity and hypertriglyceridemia through the modulation of lipid metabolism in adipocytes and myocytes. J Med Food. 2019; 22:779–788. PMID: 31210578.
Article
35. Rains TM, Agarwal S, Maki KC. Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem. 2011; 22:1–7. PMID: 21115335.
Article
36. Sirichaiwetchakoon K, Lowe GM, Kupittayanant S, Churproong S, Eumkeb G. Pluchea indica (L.) Less. tea ameliorates hyperglycemia, dyslipidemia, and obesity in high fat diet-fed mice. Evid Based Complement Alternat Med. 2020; 2020:8746137. PMID: 32595747.
37. Wang J, Zheng D, Huang F, Zhao A, Kuang J, Ren Z, Chen T, Lei J, Lin J, Wang X, et al. Theabrownin and Poria cocos polysaccharide improve lipid metabolism via modulation of bile acid and fatty acid metabolism. Front Pharmacol. 2022; 13:875549. PMID: 35833020.
Article
38. Xu J, Wang W, Liang X, Li P, Zou Y, Du X. Inhibitory effect of the theabrownin and tea polysaccharide extracts of dark tea on lipase. J Phys Conf Ser. 2020; 1549:032048.
Article
39. Giordano Attianese GM, Desvergne B. Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function. Nucl Recept Signal. 2015; 13:e001. PMID: 25945080.
Article
Full Text Links
  • NRP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr